Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to 113.47%.

  • Biomerica's EBIT Margin fell 527700.0% to 113.47% in Q4 2025 from the same period last year, while for Nov 2025 it was 118.1%, marking a year-over-year decrease of 124900.0%. This contributed to the annual value of 96.72% for FY2025, which is 208600.0% up from last year.
  • Per Biomerica's latest filing, its EBIT Margin stood at 113.47% for Q4 2025, which was down 527700.0% from 81.01% recorded in Q3 2025.
  • In the past 5 years, Biomerica's EBIT Margin registered a high of 1.4% during Q1 2022, and its lowest value of 208.81% during Q2 2025.
  • Its 5-year average for EBIT Margin is 105.65%, with a median of 110.27% in 2022.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 1302700bps in 2022, then crashed by -1472000bps in 2023.
  • Over the past 5 years, Biomerica's EBIT Margin (Quarter) stood at 24.31% in 2021, then plummeted by -362bps to 112.42% in 2022, then rose by 9bps to 102.62% in 2023, then surged by 41bps to 60.7% in 2024, then tumbled by -87bps to 113.47% in 2025.
  • Its EBIT Margin was 113.47% in Q4 2025, compared to 81.01% in Q3 2025 and 208.81% in Q2 2025.